Health Care & Life Sciences » Biotechnology | Labgenomics Co. Ltd.

Labgenomics Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,260
2,420
1,626
724
3,437
Depreciation, Depletion & Amortization
1,387
1,671
2,067
2,282
2,827
Other Funds
370
611
598
31
576
Funds from Operations
3,680
4,977
4,035
3,654
2,451
Changes in Working Capital
1,312
1,830
1,658
1,112
3,508
Net Operating Cash Flow
2,368
3,147
2,377
2,542
1,057
Capital Expenditures
2,767
3,436
4,626
4,076
4,305
Sale of Fixed Assets & Businesses
-
-
9
-
-
Purchase/Sale of Investments
1,135
1,247
405
1,000
4,115
Net Investing Cash Flow
3,901
4,683
5,022
5,322
8,402
Issuance/Reduction of Debt, Net
1,768
129
122
10,283
327
Net Financing Cash Flow
2,637
5,241
1,272
11,147
249
Net Change in Cash
1,103
3,705
3,917
8,367
9,212
Free Cash Flow
1,038
1,944
1,481
2,179
2,597
Other Sources
-
-
-
60
255
Change in Capital Stock
499
4,759
1,748
894
-
Exchange Rate Effect
-
-
-
-
3
Other Uses
-
-
-
307
236

About Labgenomics Co.

View Profile
Address
6/F, Korea Bio Park B
Seongnam GY 13488
Korea, Republic Of
Employees -
Website http://www.labgenomics.co.kr
Updated 09/14/2018
LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. Its products include sample and bioinformatics analysis, diagnostic checks, and other products. The company was founded on March 29, 2002 and is headquartered in Seongnam, South Korea.